{
  "metadata": {
    "corp_code": "00152385",
    "corp_name": "에이프로젠",
    "stock_code": "007460",
    "year_quarter": "2025_Q2",
    "collection_date": "2025-09-29T11:45:37.114503",
    "successful_apis": 28
  },
  "api_data": {
    "api_01": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2019.03.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "11,510,122",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,172",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2020.03.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "402,804",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,135",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2020.03.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "310,899",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,155",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2020.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "1,970,552",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,870",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2020.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "2,029,102",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,715",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2020.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "5,565,580",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,715",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2020.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "14,577,258",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,715",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2020.09.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "166,178",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,715",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2020.12.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "4,198,244",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,715",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2021.03.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "903,788",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,715",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2021.03.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "2,109,109",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,778",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2019.03.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "4,834,252",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,172",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2021.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "762,387",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,715",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2021.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "4,081,632",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,715",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2023.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "2,699,644",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,778",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2021.07.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "5,652,417",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,778",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2022.03.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "22,123",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,460",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2022.03.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "5,933,917",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,483",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2022.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "54,930",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,460",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2022.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "32,786,882",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,525",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2022.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "1,780,169",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,483",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2022.07.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "539,442",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,483",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2019.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "11,510,128",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,172",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2022.07.31",
        "isu_dcrs_stle": "-",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "520,702,874",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,798",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2022.09.30",
        "isu_dcrs_stle": "주식매수선택권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "31,000",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "999",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2022.12.31",
        "isu_dcrs_stle": "무상감자",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "507,337,712",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2023.09.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "293,733",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,532",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2023.09.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "5,874,670",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,532",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2023.10.24",
        "isu_dcrs_stle": "유상증자(제3자배정)",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "5,000,000",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,100",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2024.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "3,250,270",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "923",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2024.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "10,000,000",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,100",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2024.09.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "8,764,240",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,141",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2024.12.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "12,727,272",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,100",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2019.06.30",
        "isu_dcrs_stle": "신주인수권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "21,685,081",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,172",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2024.12.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "4,545,454",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "1,100",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2025.03.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "7,702,182",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "779",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2019.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "4,236,976",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,785",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2019.06.30",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "5,313,647",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,710",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2019.09.30",
        "isu_dcrs_stle": "신주인수권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "414,364",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,172",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2019.12.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "1,646,367",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,135",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_dcrs_de": "2019.12.31",
        "isu_dcrs_stle": "전환권행사",
        "isu_dcrs_stock_knd": "보통주",
        "isu_dcrs_qy": "672,850",
        "isu_dcrs_mstvdv_fval_amount": "500",
        "isu_dcrs_mstvdv_amount": "2,155",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_02": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "주당액면가액(원)",
        "thstrm": "500",
        "frmtrm": "500",
        "lwfr": "500",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "(연결)당기순이익(백만원)",
        "thstrm": "-30,059",
        "frmtrm": "-58,079",
        "lwfr": "-55,619",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "(별도)당기순이익(백만원)",
        "thstrm": "2,997",
        "frmtrm": "-64,281",
        "lwfr": "-66,199",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "(연결)주당순이익(원)",
        "thstrm": "-104",
        "frmtrm": "-225",
        "lwfr": "-236",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "현금배당금총액(백만원)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "주식배당금총액(백만원)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "(연결)현금배당성향(%)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "현금배당수익률(%)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "현금배당수익률(%)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "주식배당수익률(%)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "주식배당수익률(%)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "주당 현금배당금(원)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "주당 현금배당금(원)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "주당 주식배당(주)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "주당 주식배당(주)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_03": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "직접취득",
        "acqs_mth3": "장내직접취득",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "신탁계약에 의한취득",
        "acqs_mth3": "수탁자보유물량",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "신탁계약에 의한취득",
        "acqs_mth3": "현물보유량",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "신탁계약에 의한취득",
        "acqs_mth3": "현물보유량",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "신탁계약에 의한취득",
        "acqs_mth3": "소계",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "신탁계약에 의한취득",
        "acqs_mth3": "소계",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "보통주",
        "acqs_mth1": "기타취득",
        "acqs_mth2": "기타취득",
        "acqs_mth3": "기타취득",
        "bsis_qy": "20,758,761",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "20,758,761",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "기타취득",
        "acqs_mth2": "기타취득",
        "acqs_mth3": "기타취득",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "보통주",
        "acqs_mth1": "총계",
        "acqs_mth2": "총계",
        "acqs_mth3": "총계",
        "bsis_qy": "20,758,761",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "20,758,761",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "총계",
        "acqs_mth2": "총계",
        "acqs_mth3": "총계",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "직접취득",
        "acqs_mth3": "장내직접취득",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "직접취득",
        "acqs_mth3": "장외직접취득",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "직접취득",
        "acqs_mth3": "장외직접취득",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "직접취득",
        "acqs_mth3": "공개매수",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "직접취득",
        "acqs_mth3": "공개매수",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "직접취득",
        "acqs_mth3": "소계",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "직접취득",
        "acqs_mth3": "소계",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "acqs_mth1": "배당가능이익범위 이내 취득",
        "acqs_mth2": "신탁계약에 의한취득",
        "acqs_mth3": "수탁자보유물량",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_04": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "보통주",
        "nm": "(주)지베이스",
        "relate": "본인",
        "bsis_posesn_stock_co": "71,783,159",
        "bsis_posesn_stock_qota_rt": "23.60",
        "trmend_posesn_stock_co": "71,783,159",
        "trmend_posesn_stock_qota_rt": "23.02",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "보통주",
        "nm": "㈜넥스코닉스",
        "relate": "기타",
        "bsis_posesn_stock_co": "26,470,423",
        "bsis_posesn_stock_qota_rt": "8.70",
        "trmend_posesn_stock_co": "26,470,423",
        "trmend_posesn_stock_qota_rt": "8.49",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "보통주",
        "nm": "김재섭",
        "relate": "임원",
        "bsis_posesn_stock_co": "13,328,002",
        "bsis_posesn_stock_qota_rt": "4.38",
        "trmend_posesn_stock_co": "13,328,002",
        "trmend_posesn_stock_qota_rt": "4.27",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "보통주",
        "nm": "김정출",
        "relate": "계열사임원",
        "bsis_posesn_stock_co": "1,123,427",
        "bsis_posesn_stock_qota_rt": "0.37",
        "trmend_posesn_stock_co": "1,123,427",
        "trmend_posesn_stock_qota_rt": "0.36",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "보통주",
        "nm": "박미령",
        "relate": "임원",
        "bsis_posesn_stock_co": "6,739,068",
        "bsis_posesn_stock_qota_rt": "2.22",
        "trmend_posesn_stock_co": "6,739,068",
        "trmend_posesn_stock_qota_rt": "2.16",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "보통주",
        "nm": "강선주",
        "relate": "계열사임원",
        "bsis_posesn_stock_co": "198,187",
        "bsis_posesn_stock_qota_rt": "0.07",
        "trmend_posesn_stock_co": "198,187",
        "trmend_posesn_stock_qota_rt": "0.06",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "보통주",
        "nm": "계",
        "bsis_posesn_stock_co": "119,642,266",
        "bsis_posesn_stock_qota_rt": "39.34",
        "trmend_posesn_stock_co": "119,642,266",
        "trmend_posesn_stock_qota_rt": "38.37",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "stock_knd": "-",
        "nm": "계",
        "bsis_posesn_stock_co": "-",
        "bsis_posesn_stock_qota_rt": "-",
        "trmend_posesn_stock_co": "-",
        "trmend_posesn_stock_qota_rt": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_05": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "change_on": "2017년 11월 29일",
        "mxmm_shrholdr_nm": "(주)지베이스",
        "posesn_stock_co": "31,007,752",
        "qota_rt": "62.3%",
        "change_cause": "제3자배정 유상증자",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_06": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "소액주주",
        "shrholdr_co": "53,432",
        "shrholdr_tot_co": "53,441",
        "shrholdr_rate": "99.98%",
        "hold_stock_co": "131,201,840",
        "stock_tot_co": "311,826,676",
        "hold_stock_rate": "42.07%",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_07": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "nm": "김재섭",
        "sexdstn": "남",
        "birth_ym": "1963년 01월",
        "ofcps": "대표이사",
        "rgist_exctv_at": "사내이사",
        "fte_at": "상근",
        "chrg_job": "경영총괄",
        "main_career": "현) ㈜에이프로젠 대표이사\n현) ㈜에이프로젠바이오로직스 대표이사\n현) (주)에이피헬스케어\n(舊. (주)에이프로젠헬스케어앤게임즈)사내이사\n현)(주)앱튼(舊.(주)앱트뉴로사이언스) 대표이사\n현)(주)엔투텍  대표이사\n현) ㈜지베이스 사내이사\n전) 한국과학기술원 생물과학과 부교수\n전) 서울대 유전공학연구소 조교수\n전) 위스콘신대학교 연구조교수\n서울대학교 미생물학과(박사)",
        "mxmm_shrholdr_relate": "임원",
        "hffc_pd": "31개월",
        "tenure_end_on": "2025년 11월 29일",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "nm": "배윤경",
        "sexdstn": "여",
        "birth_ym": "1964년 01월",
        "ofcps": "이사",
        "rgist_exctv_at": "사내이사",
        "fte_at": "상근",
        "chrg_job": "연구개발",
        "main_career": "Ph.D University of Iowa\nMGH/Harvard Medical School, 박사후 연구원\n서울대학교 유전공학 연구소, 박사후 연구원\n전)제넥셀(주) 상무\n전)에이프로젠제약(주)  개발실 상무\n현)(주)에이프로젠바이오로직스 기획실 상무",
        "mxmm_shrholdr_relate": "-",
        "hffc_pd": "21개월",
        "tenure_end_on": "2026년 10월 13일",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "nm": "안동규",
        "sexdstn": "남",
        "birth_ym": "1956년 09월",
        "ofcps": "이사",
        "rgist_exctv_at": "사외이사",
        "fte_at": "비상근",
        "chrg_job": "사외이사",
        "main_career": "University of Iowa(MBA : 재무관리/회계학)\n전)중소기업은행 부행장(마케팅본부/글로벌자금시장본부)\n전)한국금융안전(주) 부사장\n전)중앙대학교 산업창업경영대학원 겸임교수\n전)(주)아시아나노텍 대표이사\n현)(주)제이케이앤씨 경영고문",
        "mxmm_shrholdr_relate": "-",
        "hffc_pd": "21개월",
        "tenure_end_on": "2026년 10월 13일",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "nm": "김학주",
        "sexdstn": "남",
        "birth_ym": "1957년 08월",
        "ofcps": "감사",
        "rgist_exctv_at": "감사",
        "fte_at": "상근",
        "chrg_job": "상근감사",
        "main_career": "육사35기\n전) 합참 작전부장\n전) 교육사 교훈부장\n전) 6군단장\n전) 항공작전사령관 \n전) 국방부 개혁실장\n현)(주)앱튼(舊.(주)앱트뉴로사이언스) 감사\n현)(주)엔투텍  감사",
        "mxmm_shrholdr_relate": "-",
        "hffc_pd": "88개월",
        "tenure_end_on": "2027년 04월 05일",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_08": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sexdstn": "남",
        "fo_bbm": "바이오의약품개발",
        "reform_bfe_emp_co_rgllbr": "-",
        "reform_bfe_emp_co_cnttk": "-",
        "reform_bfe_emp_co_etc": "-",
        "rgllbr_co": "58",
        "rgllbr_abacpt_labrr_co": "-",
        "cnttk_co": "-",
        "cnttk_abacpt_labrr_co": "-",
        "sm": "58",
        "avrg_cnwk_sdytrn": "3년 8개월",
        "fyer_salary_totamt": "1,572,604,000",
        "jan_salary_am": "29,140,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sexdstn": "여",
        "fo_bbm": "바이오의약품개발",
        "reform_bfe_emp_co_rgllbr": "-",
        "reform_bfe_emp_co_cnttk": "-",
        "reform_bfe_emp_co_etc": "-",
        "rgllbr_co": "95",
        "rgllbr_abacpt_labrr_co": "-",
        "cnttk_co": "-",
        "cnttk_abacpt_labrr_co": "-",
        "sm": "95",
        "avrg_cnwk_sdytrn": "4년 10개월",
        "fyer_salary_totamt": "2,356,550,000",
        "jan_salary_am": "24,508,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sexdstn": "남",
        "fo_bbm": "금속사업부문",
        "reform_bfe_emp_co_rgllbr": "-",
        "reform_bfe_emp_co_cnttk": "-",
        "reform_bfe_emp_co_etc": "-",
        "rgllbr_co": "45",
        "rgllbr_abacpt_labrr_co": "-",
        "cnttk_co": "35",
        "cnttk_abacpt_labrr_co": "-",
        "sm": "80",
        "avrg_cnwk_sdytrn": "8년 4개월",
        "fyer_salary_totamt": "157,023,000",
        "jan_salary_am": "3,859,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sexdstn": "여",
        "fo_bbm": "금속사업부문",
        "reform_bfe_emp_co_rgllbr": "-",
        "reform_bfe_emp_co_cnttk": "-",
        "reform_bfe_emp_co_etc": "-",
        "rgllbr_co": "4",
        "rgllbr_abacpt_labrr_co": "-",
        "cnttk_co": "0",
        "cnttk_abacpt_labrr_co": "-",
        "sm": "4",
        "avrg_cnwk_sdytrn": "3년 8개월",
        "fyer_salary_totamt": "46,147,000",
        "jan_salary_am": "26,939,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sexdstn": "남",
        "fo_bbm": "관리부서 및 기타",
        "reform_bfe_emp_co_rgllbr": "-",
        "reform_bfe_emp_co_cnttk": "-",
        "reform_bfe_emp_co_etc": "-",
        "rgllbr_co": "32",
        "rgllbr_abacpt_labrr_co": "-",
        "cnttk_co": "8",
        "cnttk_abacpt_labrr_co": "-",
        "sm": "40",
        "avrg_cnwk_sdytrn": "5년 1개월",
        "fyer_salary_totamt": "1,824,357,000",
        "jan_salary_am": "80,912,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sexdstn": "여",
        "fo_bbm": "관리부서 및 기타",
        "reform_bfe_emp_co_rgllbr": "-",
        "reform_bfe_emp_co_cnttk": "-",
        "reform_bfe_emp_co_etc": "-",
        "rgllbr_co": "22",
        "rgllbr_abacpt_labrr_co": "-",
        "cnttk_co": "4",
        "cnttk_abacpt_labrr_co": "-",
        "sm": "26",
        "avrg_cnwk_sdytrn": "3년 2개월",
        "fyer_salary_totamt": "423,756,000",
        "jan_salary_am": "17,773,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_09": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "nm": "-",
        "ofcps": "-",
        "mendng_totamt": "-",
        "mendng_totamt_ct_incls_mendng": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "nm": "-",
        "ofcps": "-",
        "mendng_totamt": "-",
        "mendng_totamt_ct_incls_mendng": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_10": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "nmpr": "4",
        "jan_avrg_mendng_am": "56,750,000",
        "mendng_totamt": "227,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_11": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "nm": "-",
        "ofcps": "-",
        "mendng_totamt": "-",
        "mendng_totamt_ct_incls_mendng": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_12": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "inv_prm": "주식회사 에이프로젠바이오로직스",
        "frst_acqs_de": "2018.06.13",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "307,834,000,000",
        "bsis_blce_qy": "112,830,917",
        "bsis_blce_qota_rt": "56.9",
        "bsis_blce_acntbk_amount": "307,834,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "112,830,917",
        "trmend_blce_qota_rt": "56.9",
        "trmend_blce_acntbk_amount": "307,834,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "539,078,000,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-98,318,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "inv_prm": "(주)에이피헬스케어\n\n(舊. (주)에이프로젠헬스케어앤게임즈)",
        "frst_acqs_de": "2023.12.19",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "70,000,000,000",
        "bsis_blce_qy": "97,945,206",
        "bsis_blce_qota_rt": "48.8",
        "bsis_blce_acntbk_amount": "60,000,000,000",
        "incrs_dcrs_acqs_dsps_qy": "20,000,000",
        "incrs_dcrs_acqs_dsps_amount": "10,000,000,000",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "117,945,206",
        "trmend_blce_qota_rt": "53.4",
        "trmend_blce_acntbk_amount": "70,000,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "327,801,000,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-16,346,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "inv_prm": "케이아이씨공업기계 \n(장가항) 유한공사",
        "frst_acqs_de": "2017.10.27",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "1,198,000,000",
        "bsis_blce_qy": "139,613",
        "bsis_blce_qota_rt": "100.0",
        "bsis_blce_acntbk_amount": "1,198,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "139,613",
        "trmend_blce_qota_rt": "100.0",
        "trmend_blce_acntbk_amount": "1,198,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "1,519,000,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "294,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "inv_prm": "(주)앱튼(舊.(주)앱트뉴로사이언스)",
        "frst_acqs_de": "2025.01.09",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "76,024,000,000",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "0.0",
        "bsis_blce_acntbk_amount": "-",
        "incrs_dcrs_acqs_dsps_qy": "62,140,303",
        "incrs_dcrs_acqs_dsps_amount": "76,024,000,000",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "62,140,303",
        "trmend_blce_qota_rt": "32.1",
        "trmend_blce_acntbk_amount": "76,024,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "206,349,000,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-13,438,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "inv_prm": "합계",
        "frst_acqs_de": "-",
        "invstmnt_purps": "-",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "-",
        "bsis_blce_acntbk_amount": "369,032,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "86,024,000,000",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "-",
        "trmend_blce_acntbk_amount": "455,055,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "-",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_13": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "보통주",
        "isu_stock_totqy": "5,000,000,000",
        "now_to_isu_stock_totqy": "847,873,459",
        "now_to_dcrs_stock_totqy": "536,046,783",
        "redc": "536,046,783",
        "profit_incnr": "-",
        "rdmstk_repy": "-",
        "etc": "-",
        "istc_totqy": "311,826,676",
        "tesstk_co": "20,758,761",
        "distb_stock_co": "291,067,915",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "합계",
        "isu_stock_totqy": "5,000,000,000",
        "now_to_isu_stock_totqy": "847,873,459",
        "now_to_dcrs_stock_totqy": "536,046,783",
        "redc": "536,046,783",
        "profit_incnr": "-",
        "rdmstk_repy": "-",
        "etc": "-",
        "istc_totqy": "311,826,676",
        "tesstk_co": "20,758,761",
        "distb_stock_co": "291,067,915",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "비고",
        "isu_stock_totqy": "-",
        "now_to_isu_stock_totqy": "-",
        "now_to_dcrs_stock_totqy": "-",
        "redc": "-",
        "profit_incnr": "-",
        "rdmstk_repy": "-",
        "etc": "-",
        "istc_totqy": "-",
        "tesstk_co": "-",
        "distb_stock_co": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_14": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "(주)에이프로젠(제27회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "사모",
        "isu_de": "2023.02.20",
        "facvalu_totamt": "40,000,000,000",
        "intrt": "6",
        "evl_grad_instt": "-",
        "mtd": "2026.02.20",
        "repy_at": "일부상환",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "(주)에이프로젠(제28회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "사모",
        "isu_de": "2023.04.03",
        "facvalu_totamt": "20,000,000,000",
        "intrt": "6",
        "evl_grad_instt": "-",
        "mtd": "2026.04.03",
        "repy_at": "일부상환",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "(주)에이프로젠(제29회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "사모",
        "isu_de": "2023.09.14",
        "facvalu_totamt": "70,000,000,000",
        "intrt": "4",
        "evl_grad_instt": "-",
        "mtd": "2028.09.14",
        "repy_at": "일부상환",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "(주)에이프로젠바이오로직스(제14회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "사모",
        "isu_de": "2023.04.14",
        "facvalu_totamt": "40,000,000,000",
        "intrt": "6",
        "evl_grad_instt": "-",
        "mtd": "2028.04.14",
        "repy_at": "상환완료",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "(주)에이프로젠바이오로직스(제15회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "사모",
        "isu_de": "2023.04.24",
        "facvalu_totamt": "20,000,000,000",
        "intrt": "6",
        "evl_grad_instt": "-",
        "mtd": "2028.04.24",
        "repy_at": "상환완료",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "(주)에이프로젠바이오로직스(제16회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "사모",
        "isu_de": "2024.07.19",
        "facvalu_totamt": "40,000,000,000",
        "intrt": "5",
        "evl_grad_instt": "-",
        "mtd": "2029.07.19",
        "repy_at": "미상환",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "(주)에이프로젠바이오로직스(제17회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "사모",
        "isu_de": "2025.03.27",
        "facvalu_totamt": "65,000,000,000",
        "intrt": "3",
        "evl_grad_instt": "-",
        "mtd": "2030.03.27",
        "repy_at": "미상환",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "(주)에이피헬스케어\n(舊. (주)에이프로젠헬스케어앤게임즈)\n(제6회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "공모",
        "isu_de": "2023.07.25",
        "facvalu_totamt": "40,000,000,000",
        "intrt": "5",
        "evl_grad_instt": "B-\n(NICE신용평가,\n한국신용평가)",
        "mtd": "2026.07.25",
        "repy_at": "일부상환",
        "mngt_cmpny": "신한투자증권",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "지오릿에너지㈜\n(現. ㈜앱튼)\n(제6회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "사모",
        "isu_de": "2024.09.09",
        "facvalu_totamt": "21,000,000,000",
        "intrt": "3.0",
        "evl_grad_instt": "-",
        "mtd": "2027.09.09",
        "repy_at": "미상환",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "지오릿에너지㈜\n(現. ㈜앱튼)\n(제7회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "사모",
        "isu_de": "2024.09.09",
        "facvalu_totamt": "4,200,000,000",
        "intrt": "2.9",
        "evl_grad_instt": "-",
        "mtd": "2027.09.09",
        "repy_at": "미상환",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "지오릿에너지㈜\n(現. ㈜앱튼)\n(제9회차)",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "사모",
        "isu_de": "2024.12.03",
        "facvalu_totamt": "100,000,000,000",
        "intrt": "3.0",
        "evl_grad_instt": "-",
        "mtd": "2027.12.03",
        "repy_at": "미상환",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "isu_cmpny": "합 계",
        "scrits_knd_nm": "-",
        "isu_mth_nm": "-",
        "isu_de": "-",
        "facvalu_totamt": "460,200,000,000",
        "intrt": "-",
        "evl_grad_instt": "-",
        "mtd": "-",
        "repy_at": "-",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_15": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "공모",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy3_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "사모",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy3_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "합계",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy3_excess": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_16": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "공모",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "isu_lmt": "-",
        "remndr_lmt": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "사모",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "isu_lmt": "-",
        "remndr_lmt": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "합계",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "isu_lmt": "-",
        "remndr_lmt": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_17": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "754,000,000",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "공모",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy1_below": "754,000,000",
        "yy3_excess_yy4_below": "-",
        "yy4_excess_yy5_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy10_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "377,200,000,000",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "사모",
        "yy1_excess_yy2_below": "0",
        "yy2_excess_yy3_below": "125,200,000,000",
        "yy1_below": "30,000,000,000",
        "yy3_excess_yy4_below": "117,000,000,000",
        "yy4_excess_yy5_below": "105,000,000,000",
        "yy5_excess_yy10_below": "-",
        "yy10_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "377,954,000,000",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "합계",
        "yy1_excess_yy2_below": "0",
        "yy2_excess_yy3_below": "125,200,000,000",
        "yy1_below": "30,754,000,000",
        "yy3_excess_yy4_below": "117,000,000,000",
        "yy4_excess_yy5_below": "105,000,000,000",
        "yy5_excess_yy10_below": "-",
        "yy10_excess": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_18": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "공모",
        "yy1_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy1_excess_yy5_below": "-",
        "yy10_excess_yy15_below": "-",
        "yy15_excess_yy20_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "사모",
        "yy1_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy1_excess_yy5_below": "-",
        "yy10_excess_yy15_below": "-",
        "yy15_excess_yy20_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "합계",
        "yy1_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy1_excess_yy5_below": "-",
        "yy10_excess_yy15_below": "-",
        "yy15_excess_yy20_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_19": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "공모",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy1_below": "-",
        "yy3_excess_yy4_below": "-",
        "yy4_excess_yy5_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "yy10_excess_yy20_below": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "사모",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy1_below": "-",
        "yy3_excess_yy4_below": "-",
        "yy4_excess_yy5_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "yy10_excess_yy20_below": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "합계",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy1_below": "-",
        "yy3_excess_yy4_below": "-",
        "yy4_excess_yy5_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "yy10_excess_yy20_below": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_20": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제55기\n(당기)",
        "adtor": "삼덕회계법인",
        "adt_reprt_spcmnt_matter": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제55기\n(당기)",
        "adtor": "삼덕회계법인",
        "adt_reprt_spcmnt_matter": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제54기\n(전기)",
        "adtor": "인덕회계법인",
        "adt_opinion": "적정의견",
        "adt_reprt_spcmnt_matter": "-",
        "emphs_matter": "해당사항 없음",
        "core_adt_matter": "영업권 손상평가",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제54기\n(전기)",
        "adtor": "인덕회계법인",
        "adt_opinion": "적정의견",
        "adt_reprt_spcmnt_matter": "-",
        "emphs_matter": "해당사항 없음",
        "core_adt_matter": "영업손실 발생에 따른 사업부 손상 평가",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제53기\n(전전기)",
        "adtor": "인덕회계법인",
        "adt_opinion": "적정의견",
        "adt_reprt_spcmnt_matter": "-",
        "emphs_matter": "해당사항 없음",
        "core_adt_matter": "영업권 손상평가",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제53기\n(전전기)",
        "adtor": "인덕회계법인",
        "adt_opinion": "적정의견",
        "adt_reprt_spcmnt_matter": "-",
        "emphs_matter": "해당사항 없음",
        "core_adt_matter": "영업손실 발생에 따른 사업부 손상 평가",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_21": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제55기(당기)",
        "adtor": "삼덕회계법인",
        "cn": "재고실사,분반기검토\n중간감사,기말감사",
        "mendng": "-",
        "tot_reqre_time": "-",
        "adt_cntrct_dtls_mendng": "320백만원",
        "adt_cntrct_dtls_time": "2,844H",
        "real_exc_dtls_mendng": "-",
        "real_exc_dtls_time": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제54기(전기)",
        "adtor": "인덕회계법인",
        "cn": "재고실사,분반기검토\n중간감사,기말감사",
        "mendng": "-",
        "tot_reqre_time": "-",
        "adt_cntrct_dtls_mendng": "560백만원",
        "adt_cntrct_dtls_time": "3,733H",
        "real_exc_dtls_mendng": "560백만원",
        "real_exc_dtls_time": "3,737H",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제53기(전전기)",
        "adtor": "인덕회계법인",
        "cn": "재고실사,분반기검토\n중간감사,기말감사",
        "mendng": "-",
        "tot_reqre_time": "-",
        "adt_cntrct_dtls_mendng": "480백만원",
        "adt_cntrct_dtls_time": "3,411H",
        "real_exc_dtls_mendng": "480백만원",
        "real_exc_dtls_time": "3,473H",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_22": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제55기(당기)",
        "cntrct_cncls_de": "-",
        "servc_cn": "-",
        "servc_exc_pd": "-",
        "servc_mendng": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제55기(당기)",
        "cntrct_cncls_de": "-",
        "servc_cn": "-",
        "servc_exc_pd": "-",
        "servc_mendng": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제54기(전기)",
        "cntrct_cncls_de": "-",
        "servc_cn": "-",
        "servc_exc_pd": "-",
        "servc_mendng": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제54기(전기)",
        "cntrct_cncls_de": "-",
        "servc_cn": "-",
        "servc_exc_pd": "-",
        "servc_mendng": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제53기(전전기)",
        "cntrct_cncls_de": "-",
        "servc_cn": "-",
        "servc_exc_pd": "-",
        "servc_mendng": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "bsns_year": "제53기(전전기)",
        "cntrct_cncls_de": "-",
        "servc_cn": "-",
        "servc_exc_pd": "-",
        "servc_mendng": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_23": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "drctr_co": "3",
        "otcmp_drctr_co": "1",
        "apnt": "-",
        "rlsofc": "-",
        "mdstrm_resig": "1",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_24": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "미등기임원",
        "fyer_salary_totamt": "571,169,000",
        "jan_salary_am": "45,688,000",
        "nmpr": "13",
        "rm": "　-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_25": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "등기이사",
        "nmpr": "3",
        "gmtsck_confm_amount": "3,000,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "감사",
        "nmpr": "1",
        "gmtsck_confm_amount": "500,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_26": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "등기이사(사외이사, 감사위원회 위원 제외)",
        "nmpr": "2",
        "pymnt_totamt": "185,000,000",
        "psn1_avrg_pymntamt": "92,500,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "사외이사(감사위원회 위원 제외)",
        "nmpr": "1",
        "pymnt_totamt": "30,000,000",
        "psn1_avrg_pymntamt": "30,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "감사위원회 위원",
        "nmpr": "-",
        "pymnt_totamt": "-",
        "psn1_avrg_pymntamt": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se": "감사",
        "nmpr": "1",
        "pymnt_totamt": "12,000,000",
        "psn1_avrg_pymntamt": "12,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_27": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)에이피헬스케어\n(舊. (주)에이프로젠헬스케어앤게임즈)\n신주인수권부사채",
        "tm": "6",
        "pay_de": "2023.07.25",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "운영자금",
        "rs_cptal_use_plan_prcure_amount": "40,000,000,000",
        "real_cptal_use_dtls_cn": "㈜에이프로젠과 체결한 [Trastuzumab Biosimilar(AP063) \n공동개발계약]에 따른 개발비 지급",
        "real_cptal_use_dtls_amount": "40,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)에이프로젠바이오로직스\n유상증자",
        "tm": "-",
        "pay_de": "2024.06.27",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "운영자금",
        "rs_cptal_use_plan_prcure_amount": "24,866,000,000",
        "real_cptal_use_dtls_cn": "- 운영자금(원부자재 매입, 외주가공비 등)\n- 유상증자 수수료\n- 차입금 상환 및 이자비용",
        "real_cptal_use_dtls_amount": "24,866,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)에이프로젠바이오로직스\n유상증자",
        "tm": "-",
        "pay_de": "2024.06.27",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "채무상환자금",
        "rs_cptal_use_plan_prcure_amount": "30,892,000,000",
        "real_cptal_use_dtls_cn": "- 차입금 상환",
        "real_cptal_use_dtls_amount": "30,892,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)에이피헬스케어\n(舊. (주)에이프로젠헬스케어앤게임즈)\n유상증자",
        "tm": "-",
        "pay_de": "2024.10.31",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "운영자금",
        "rs_cptal_use_plan_prcure_amount": "35,000,000,000",
        "real_cptal_use_dtls_cn": "㈜에이프로젠과 체결한 [Adalimumab Biosimilar\n(AP096)공동개발계약]에 따른 개발비 지급",
        "real_cptal_use_dtls_amount": "35,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)에이피헬스케어\n(舊. (주)에이프로젠헬스케어앤게임즈)\n유상증자",
        "tm": "-",
        "pay_de": "2024.10.31",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "채무상환자금",
        "rs_cptal_use_plan_prcure_amount": "7,718,000,000",
        "real_cptal_use_dtls_cn": "(주)에이피헬스케어\n6회차 신주인수권부사채 조기상환 대금 지급",
        "real_cptal_use_dtls_amount": "7,718,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_28": [
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "전환사채발행",
        "tm": "27",
        "pay_de": "2023.02.20",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "(주)에이프로젠바이오로직스 유상증자 대금 납입",
        "real_cptal_use_dtls_amount": "40,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "타법인증권 취득 자금",
        "mtrpt_cptal_use_plan_prcure_amount": "40,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "전환사채발행",
        "tm": "28",
        "pay_de": "2023.04.03",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "재무구조개선자금",
        "real_cptal_use_dtls_amount": "20,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "재무구조개선자금",
        "mtrpt_cptal_use_plan_prcure_amount": "20,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "전환사채발행",
        "tm": "29",
        "pay_de": "2023.09.14",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "제17회 사모 전환사채(만기상환)",
        "real_cptal_use_dtls_amount": "70,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "채무상환자금",
        "mtrpt_cptal_use_plan_prcure_amount": "70,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)에이프로젠바이오로직스 전환사채",
        "tm": "14",
        "pay_de": "2023.04.14",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "바이오사업부문 운영자금 사용\n(원부자재 매입, 임금 등)",
        "real_cptal_use_dtls_amount": "40,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "40,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)에이프로젠바이오로직스 전환사채",
        "tm": "15",
        "pay_de": "2023.04.24",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "㈜에이프로젠헬스케어앤게임즈\n3자배정 유상증자 참여",
        "real_cptal_use_dtls_amount": "20,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "타법인 증권취득",
        "mtrpt_cptal_use_plan_prcure_amount": "20,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)에이프로젠바이오로직스 전환사채",
        "tm": "16",
        "pay_de": "2024.07.19",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "제14회 전환사채 조기상환",
        "real_cptal_use_dtls_amount": "40,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "채무상환자금",
        "mtrpt_cptal_use_plan_prcure_amount": "40,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)에이프로젠바이오로직스 전환사채",
        "tm": "17",
        "pay_de": "2025.03.27",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "제약사업부문/바이오사업부문 운영자금 사용\n(원부자재 매입, 임금 등)",
        "real_cptal_use_dtls_amount": "13,400,000,000",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "13,400,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)에이프로젠바이오로직스 전환사채",
        "tm": "17",
        "pay_de": "2025.03.27",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "몬타나 신기술조합 제72호 출자",
        "real_cptal_use_dtls_amount": "51,600,000,000",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "타법인 증권취득",
        "mtrpt_cptal_use_plan_prcure_amount": "51,600,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n유상증자",
        "tm": "-",
        "pay_de": "2023.02.23",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "타법인 증권 취득",
        "real_cptal_use_dtls_amount": "5,000,000,000",
        "dffrnc_occrrnc_resn": "주1)",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "5,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n유상증자",
        "tm": "-",
        "pay_de": "2023.02.23",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "타법인 증권 취득",
        "real_cptal_use_dtls_amount": "5,000,000,000",
        "dffrnc_occrrnc_resn": "주1)",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "기타자금",
        "mtrpt_cptal_use_plan_prcure_amount": "5,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n전환사채",
        "tm": "4",
        "pay_de": "2023.04.18",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "타법인 증권 취득",
        "real_cptal_use_dtls_amount": "10,000,000,000",
        "dffrnc_occrrnc_resn": "주1)",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "기타자금",
        "mtrpt_cptal_use_plan_prcure_amount": "10,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n전환사채",
        "tm": "5",
        "pay_de": "2023.04.18",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "타법인 증권 취득",
        "real_cptal_use_dtls_amount": "15,000,000,000",
        "dffrnc_occrrnc_resn": "주1)",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "기타자금",
        "mtrpt_cptal_use_plan_prcure_amount": "15,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n유상증자",
        "tm": "-",
        "pay_de": "2023.05.04",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "타법인 증권 취득",
        "real_cptal_use_dtls_amount": "6,665,000,000",
        "dffrnc_occrrnc_resn": "주1)",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "기타자금",
        "mtrpt_cptal_use_plan_prcure_amount": "6,665,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n유상증자",
        "tm": "-",
        "pay_de": "2023.05.04",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "타법인 증권 취득",
        "real_cptal_use_dtls_amount": "10,000,000,000",
        "dffrnc_occrrnc_resn": "주1)",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "기타자금",
        "mtrpt_cptal_use_plan_prcure_amount": "10,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n전환사채",
        "tm": "6",
        "pay_de": "2024.09.09",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "해외법인 운영자금",
        "real_cptal_use_dtls_amount": "13,420,000,000",
        "dffrnc_occrrnc_resn": "주2)",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "21,000,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n전환사채",
        "tm": "7",
        "pay_de": "2024.09.09",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "타법인 증권 취득",
        "real_cptal_use_dtls_amount": "4,200,000,000",
        "dffrnc_occrrnc_resn": "주1)",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "4,200,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n전환사채",
        "tm": "9",
        "pay_de": "2024.12.03",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "신규사업 관련 운영자금(기술양수도 계약금, 공동연구개발비, 기계장치 매입 등)",
        "real_cptal_use_dtls_amount": "41,293,000,000",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "41,293,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n전환사채",
        "tm": "9",
        "pay_de": "2024.12.03",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "㈜에이프로젠, ㈜에이프로젠바이오로직스 대여금 지급",
        "real_cptal_use_dtls_amount": "14,500,000,000",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "14,500,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n전환사채",
        "tm": "9",
        "pay_de": "2024.12.03",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "타법인 증권 취득",
        "real_cptal_use_dtls_amount": "9,134,000,000",
        "dffrnc_occrrnc_resn": "주1)",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "9,134,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n전환사채",
        "tm": "9",
        "pay_de": "2024.12.03",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "-",
        "real_cptal_use_dtls_amount": "0",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "35,073,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n유상증자",
        "tm": "-",
        "pay_de": "2025.05.26",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "-",
        "real_cptal_use_dtls_amount": "0",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "17,500,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814003014",
        "corp_cls": "Y",
        "corp_code": "00152385",
        "corp_name": "에이프로젠",
        "se_nm": "(주)앱튼(舊.(주)앱트뉴로사이언스)\n유상증자",
        "tm": "-",
        "pay_de": "2025.05.26",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "-",
        "real_cptal_use_dtls_amount": "0",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "운영자금",
        "mtrpt_cptal_use_plan_prcure_amount": "17,500,000,000",
        "stlm_dt": "2025-06-30"
      }
    ]
  }
}